Drug
Dociparstat
Dociparstat: highest development phase Phase 3, developed by Jazz Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dociparstat NCT04571645 | Phase 3 | Acute Myeloid Leukemia |
Latest
No recent events.
Follow Dociparstat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.